{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:15:26Z","timestamp":1791062126823,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jdiacomp.2026.109271","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:53:10Z","timestamp":1769442790000},"page":"109271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of GLP-1 receptor agonists on vascular dementia: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"40","author":[{"given":"Maria-Ioanna","family":"Stefanou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Tentolouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Panagiotopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Theodorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annerose","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Athanasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaia","family":"Lambadiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melpomeni","family":"Peppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios P.","family":"Paraskevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Giannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Siasos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Ziemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tsivgoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2026.109271_bb0005","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/jama.2025.1897","article-title":"Changing story of the dementia epidemic","volume":"333","author":"Stallard","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0010","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0015","first-page":"S4","article-title":"Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group","volume":"54","author":"Lobo","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0020","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1474-4422(18)30442-3","article-title":"Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study","volume":"18","author":"Pendlebury","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0025","doi-asserted-by":"crossref","first-page":"CXI","DOI":"10.1177\/23969873211012132","article-title":"ESO Guideline on covert cerebral small vessel disease","volume":"6","author":"Wardlaw","year":"2021","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13311-021-01170-y","article-title":"Vascular Cognitive Impairment (VCI)","volume":"19","author":"Rundek","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0035","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/dc21-0601","article-title":"Type 2 diabetes, glycemic control, and their association with dementia and its major subtypes: findings from the Swedish National Diabetes Register","volume":"45","author":"Celis-Morales","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0040","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1212\/WNL.0b013e3181f4d7f8","article-title":"Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study","volume":"75","author":"Ahtiluoto","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11892-016-0775-x","article-title":"Diabetes and cognitive impairment","volume":"16","author":"Zilliox","year":"2016","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040778","article-title":"Type 2 diabetes mellitus as a risk factor for Alzheimer\u2019s disease: review and Meta-analysis","volume":"10","author":"Athanasaki","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0055","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.2337\/dc25-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice C","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0060","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/23969873241234238","article-title":"Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP\/GLP-1 receptor agonist tirzepatide for type 2 diabetes: a systematic review and meta-analysis","volume":"9","author":"Stefanou","year":"2024","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0065","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00415-020-09813-4","article-title":"GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis","volume":"267","author":"Malhotra","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0070","doi-asserted-by":"crossref","DOI":"10.1177\/17562864241281903","article-title":"Risk of major adverse cardiovascular events and all-cause mortality under treatment with GLP-1 RAs or the dual GIP\/GLP-1 receptor agonist tirzepatide in overweight or obese adults without diabetes: a systematic review and meta-analysis","volume":"17","author":"Stefanou","year":"2024","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0075","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0080","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jamaneurol.2025.0360","article-title":"Cardioprotective glucose-lowering agents and dementia risk: a systematic review and meta-analysis","volume":"82","author":"Seminer","year":"2025","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113537","article-title":"Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative disorders: a large-scale propensity-matched cohort study","volume":"143","author":"Siddeeque","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109952","article-title":"Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson\u2019s and Alzheimer\u2019s disease clinical trials: a revolution in the making?","volume":"253","author":"Holscher","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3233\/ADR-230181","article-title":"Clinical evidence for GLP-1 receptor agonists in Alzheimer\u2019s disease: a systematic review","volume":"8","author":"Liang","year":"2024","journal-title":"J Alzheimers Dis Rep"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0105","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0120","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/23969873241251931","article-title":"Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: a systematic review and meta-analysis","volume":"9","author":"Palaiodimou","year":"2024","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11174981","article-title":"Early anticoagulation in patients with acute ischemic stroke due to atrial fibrillation: a systematic review and meta-analysis","volume":"11","author":"Palaiodimou","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0130","series-title":"Cochrane handbook for systematic reviews of interventions","first-page":"241","article-title":"Analysing data and undertaking meta-analyses","author":"Deeks","year":"2019"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0140","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0145","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0150","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0155","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0160","article-title":"Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers","volume":"8","author":"Norgaard","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0165","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/ATVBAHA.119.311908","article-title":"Epidemiology of vascular dementia","volume":"39","author":"Wolters","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0170","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/01.WNL.0000160115.55756.DE","article-title":"Determinants of vascular dementia in the Cardiovascular Health Cognition Study","volume":"64","author":"Kuller","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000064928","article-title":"Diabetes mellitus and the risk of dementia, Alzheimer\u2019s disease and vascular cognitive impairment in the Canadian Study of Health and Aging","volume":"14","author":"MacKnight","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0180","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15-year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4093\/dmj.2018.0216","article-title":"Incidence and risk factors for dementia in type 2 diabetes mellitus: a nationwide population-based study in Korea","volume":"44","author":"Yu","year":"2020","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0190","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2337\/dc21-0957","article-title":"Risk of incident dementia according to glycemic status and comorbidities of hyperglycemia: a nationwide population-based cohort study","volume":"45","author":"Kim","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0195","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1161\/01.STR.0000083050.44441.10","article-title":"Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study","volume":"34","author":"van Straaten","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0200","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jamaneurol.2025.3242","article-title":"Revised diagnostic criteria for vascular cognitive impairment and dementia-the VasCog-2-WSO criteria","volume":"82","author":"VasCog WSOCC","year":"2025","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0205","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0210","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/CIRCULATIONAHA.122.059595","article-title":"GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes","volume":"146","author":"Marx","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0215","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","article-title":"Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70358","article-title":"Efficacy and safety of GLP-1 and dual GIP\/GLP-1 receptor agonists in idiopathic intracranial hypertension: a systematic review and meta-analysis","volume":"32","author":"Stefanou","year":"2025","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0225","first-page":"2449","article-title":"Liraglutide improves cognitive impairment via the AMPK and PI3K\/Akt signaling pathways in type 2 diabetic rats","volume":"18","author":"Yang","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/js.2017-00300","article-title":"Long-acting GLP-1 receptor agonist exenatide influence on the autonomic cardiac sympatho-vagal balance","volume":"2","author":"Cacciatori","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0235","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/jon.12993","article-title":"Autonomic dysfunction in amyotrophic lateral sclerosis: a neurophysiological and neurosonology study","volume":"32","author":"Papadopoulou","year":"2022","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0240","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.2015.4669","article-title":"Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis","volume":"313","author":"Ossenkoppele","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12122904","article-title":"Cerebrospinal fluid classical biomarker levels in mixed vs. pure A(+)T(+) (A(+)T(1)(+)) Alzheimer\u2019s disease","volume":"12","author":"Tsantzali","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.jdiacomp.2026.109271_bb0250","article-title":"Canadian consensus conference on diagnosis and treatment of dementia (CCCDTD)5: guidelines for management of vascular cognitive impairment","volume":"6","author":"Smith","year":"2020","journal-title":"Alzheimers Dement (N Y)"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:14:55Z","timestamp":1770826495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872726000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1056872726000164"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109271","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of GLP-1 receptor agonists on vascular dementia: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109271"}}